Yousefi A, Najafi M, Motamed F, Mahmoudi E, Zare BA, Sadr M, Rahmani F, Farhmand F, Khodadad A, Fallahi G, Rezaei N

Idioma: Ingles.
Referencias bibliográficas: 37
Paginas: 1021-1025
Archivo PDF: 138.75 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Gossard AA, Lindor KD. Autoimmune hepatitis: a review. J Gastroenterol 2012: 47: 498-503. doi: 10.1007/s00535-012- 0586-z.

2. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006: 354: 54-66. doi: 354/1/54 [pii] 10.1056/NEJMra050408.

3. Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis. J Hepatol 2000: 32: 181-97.

4. Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children: what is different from adult AIH? Semin Liver Dis 2009: 29: 297-306. doi: 10.1055/s-0029-1233529.

5. Beland K, Lapierre P, Alvarez F. Influence of genes, sex, age and environment on the onset of autoimmune hepatitis. World J Gastroenterol 2009; 15: 1025-34.

6. Wong RJ, Gish R, Frederick T, Bzowej N, Frenette C. The impact of race/ethnicity on the clinical epidemiology of autoimmune hepatitis. J Clin Gastroenterol 2012: 46: 155-61. doi: 10.1097/MCG.0b013e318228b781.

7. Czaja AJ. Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis. Clin Gastroenterol Hepatol 2008; 6: 379-88. doi: 10.1016/ j.cgh.2007.12.048S1542-3565(07)01251-7 [pii].

8. Vergani D, Mieli-Vergani G. Aetiopathogenesis of autoimmune hepatitis. World J Gastroenterol 2008; 14: 3306-12.

9. Kahraman A, Gerken G, Canbay A. Apoptosis in immune-mediated liver diseases. Dig Dis 2010; 28: 144-9. doi: 10.1159/ 000299799000299799 [pii].

10. Vierling JM. Autoimmune hepatitis and antigen-specific T regulatory cells: when can we send in the regulators? Hepatology 2011; 53: 385-8. doi: 10.1002/hep.24153.

11. Santodomingo-Garzon T, Swain MG. Role of NKT cells in autoimmune liver disease. Autoimmun Rev 2011: 10: 793-800. doi: 10.1016/j.autrev.2011.06.003S1568-9972(11)00145-5 [pii].

12. Zhao L, Tang Y, You Z, Wang Q, Liang S, Han X, Qiu D, et al. Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLoS One 2011:6:e18909. doi: 10.1371/ journal.pone.0018909.

13. Popko K, Gorska E, Demkow U. Influence of interleukin-6 and G174C polymorphism in IL-6 gene on obesity and energy balance. Eur J Med Res 2010:15 Suppl 2:123-7.

14. Vasilyev FF, Silkov AN, Sennikov SV. Relationship between interleukin-1 type 1 and 2 receptor gene polymorphisms and the expression level of membrane-bound receptors. Cell Mol Immunol 2015; 12: 222-30. doi: 10.1038/cmi.2014.43.

15. Amirzargar A, Shahram F, Nikoopour E, Rezaei N, Saeedfar K, Ziaei N, Davatchi F. Proinflammatory cytokine gene polymorphisms in Behcet’s disease. Eur Cytokine Netw 2010; 21: 292-6. doi: 10.1684/ecn.2009.0209.

16. Barkhordari E, Rezaei N, Ansaripour B, Larki P, Alighardashi M, Ahmadi-Ashtiani HR, Mahmoudi M, et al. Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome. J Clin Immunol 2010; 30: 74-9. doi: 10.1007/s10875-009- 9342-4.

17. Rezaei N, Amirzargar AA, Shakiba Y, Mahmoudi M, Moradi B, Aghamohammadi A. Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol 2009; 155: 21-7. doi: 10.1111/ j.1365-2249.2008.03790.x.

18. Mahdaviani SA, Rezaei N, Moradi B, Dorkhosh S, Amirzargar AA, Movahedi M. Proinflammatory cytokine gene polymorphisms among Iranian patients with asthma. J Clin Immunol 2009; 29: 57-62. doi: 10.1007/s10875-008-9232-1.

19. Amirzargar AA, Bagheri M, Ghavamzadeh A, Alimoghadam K, Khosravi F, Rezaei N, Moheydin M, et al. Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. Int J Immunogenet 2005; 32: 167-71. doi: 10.1111/j.1744-313X.2005.00502.x.

20. Amirzargar AA, Rezaei N, Jabbari H, Danesh AA, Khosravi F, Hajabdolbaghi M, Yalda A, et al. Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. Eur Cytokine Netw 2006; 17: 84-9.

21. Fan LY, Tu XQ, Zhu Y, Pfeiffer T, Feltens R, Stoecker W, Zhong RQ. Genetic association of cytokines polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. World J Gastroenterol 2005; 11: 2768-72.

22. Assari R, Aghighi Y, Ziaee V, Sadr M, Rezaei A, Rahmani F, Sadr Z, et al. Interleukin-4 cytokine single nucleotide polymorphisms in kawasaki disease: A case-control study and a review of knowledge. Internat J Rheumat Dis 2016. doi: 10.1111/1756-185X.12968.

23. Assari R, Aghighi Y, Ziaee V, Sadr M, Rahmani F, Rezaei A, Sadr Z, et al. Pro-inflammatory cytokine single nucleotide polymorphisms in Kawasaki disease. Internat J Rheumat Diseases 2016. doi: 10.1111/1756-185X.12911.

24. Eskandari V, Amirzargar AA, Mahmoudi MJ, Rahnemoon Z, Rahmani F, Sadati S, Rahmati Z, et al. Gene expression and levels of IL-6 and TNF alpha in PBMCs correlate with severity and functional class in patients with chronic heart failure. Ir J Med Sci 2017. doi: 10.1007/s11845-017-1680-2.

25. Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, Bittencourt PL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169- 76. doi: 10.1002/hep.22322.

26. Amirzargar AA, Naroueynejad M, Khosravi F, Dianat SS, Rezaei N, Mytilineos J, Nikbin B, et al. Cytokine single nucleotide polymorphisms in Iranian populations. Eur Cytokine Netw 2008; 19: 104-12. doi: 10.1684/ecn.2008.0122.

27. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.

28. Muratori L, Longhi MS. The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies. J Autoimmun 2013; 46: 74-80. doi: 10.1016/j.jaut.2013.06.016.

29. Liberal R, Vergani D, Mieli-Vergani G. Update on Autoimmune Hepatitis. J Clin Transl Hepatol 2015; 3: 42-52. doi: 10.14218/jcth.2014.00032.

30. Thomas-Dupont P, Remes-Troche JM, Izaguirre-Hernández IY, Sánchez-Vargas LA, Maldonado-Rentería M de J, Hernández-Flores KG, Torre A, et al. Elevated circulating levels of IL-21 and IL-22 define a cytokine signature profile in type 2 autoimmune hepatitis patients. Ann Hepatol 2016: 15: 550-8.

31. Maggiore G, De Benedetti F, Massa M, Pignatti P, Martini A. Circulating levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in children with autoimmune hepatitis. J Pediatr Gastroenterol Nutr 1995: 20: 23-7.

32. Bostrom EA, Ekstedt M, Kechagias S, Sjowall C, Bokarewa MI, Almer S. Resistin is associated with breach of tolerance and anti-nuclear antibodies in patients with hepatobiliary inflammation. Scand J Immunol 2011; 74: 463-70. doi: 10.1111/j.1365-3083.2011.02592.x.

33. Cookson S, Constantini PK, Clare M, Underhill JA, Bernal W, Czaja AJ, Donaldson PT, et al. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 1999; 30: 851-6. doi: S0270913999004310 [pii]10.1002/hep.510300412.

34. al-Wabel A, al-Janadi M, Raziuddin S. Cytokine profile of viral and autoimmune chronic active hepatitis. J Allergy Clin Immunol 1993; 92: 902-8. doi: 0091-6749(93)90068-Q [pii].

35. Stoica AL, Stoica E, Constantinescu I, Uscatescu V, Ginghina C. Interleukin-6 and interleukin-10 gene polymorphism, endothelial dysfunction, and postoperative prognosis in patients with peripheral arterial disease. J Vasc Surg 2010; 52: 103-9. doi: 10.1016/j.jvs.2010.01.088.

36. Aureli A, Sebastiani P, Del Beato T, Marimpietri AE, Graziani A, Sechi E, Di Loreto S, et al. Involvement of IL-6 and IL-1 receptor antagonist on intellectual disability. Immunol Lett 2014; 162: 124-31. doi: 10.1016/j.imlet.2014.08.003.

37. Movahedi M, Tavakol M, Rahmani F, Amirzargare AA, Bidokie AZ, Heidari K, Gharagozlou M, et al. Interleukin-6 and tumor necrosis factor-alpha gene polymorphisms in chronic idiopathic urticaria. Allergol Immunopathol (Madr) 2014; 42: 533-8. doi: 10.1016/j.aller.2013.06.004.